✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

Fredun Pharmaceuticals Ltd.

FREDUN

Market Cap
₹944 Cr.
P/E
28.88

Fredun Pharmaceuticals Ltd.

  • Fredun Pharma
  • Syncom Formulations
  • Beta Drugs
  • TJI Pharma - Small Cap

FAQs on Fredun Pharmaceuticals Ltd. Shareprice

Fredun Pharma has given lower returns compared to its competitors.
Fredun Pharma has grown at ~21.45% over the last 7yrs while peers have grown at a median rate of 40.13%

Fredun Pharma is not expensive.
Latest PE of Fredun Pharma is 28.88, while 3 year average PE is 41.61.
Also latest EV/EBITDA of Fredun Pharma is 13.35 while 3yr average is 17.82.

View FAQ's On Business

Growth Table

  • Fredun Pharmaceuticals Ltd.
  • Syncom Formulations
  • Beta Drugs

Balance Sheet

  • Fredun Pharmaceuticals Ltd.
  • Syncom Formulations
  • Beta Drugs

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Fredun Pharmaceuticals Ltd.
  • Syncom Formulations
  • Beta Drugs

Cash Flow

  • Fredun Pharmaceuticals Ltd.
  • Syncom Formulations
  • Beta Drugs

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Fredun Pharmaceuticals Ltd.
  • Syncom Formulations
  • Beta Drugs

Quarterly Results

  • Fredun Pharmaceuticals Ltd.
  • Syncom Formulations
  • Beta Drugs

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Fredun Pharmaceuticals Ltd. Financials

Balance sheet of Fredun Pharma is strong.
But short term working capital might become an issue for this company.

Yes, The net debt of Fredun Pharma is increasing.
Latest net debt of Fredun Pharma is ₹163 Crs as of Sep-25.
This is greater than Mar-25 when it was ₹157 Crs.

Yes, profit is increasing.
The profit of Fredun Pharma is ₹32.68 Crs for TTM, ₹19.74 Crs for Mar 2025 and ₹15.62 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Fredun Pharma latest dividend payout ratio is 1.67% and 3yr average dividend payout ratio is 2.24%

Companies resources are allocated to majorly unproductive assets like Inventory, Accounts Receivable

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech